21 Red Flags to Watch for in a Biotech Company
10/21/2013 8:36:51 AM
Nutty things are happening in biotech. Irrational exuberance has returned. Generalist investors with lots of money are suddenly buying these stocks first and asking questions later. Companies can fire off meaningless press releases, and be rewarded. I heard a big-time money manager talk the other day about a recent biotech IPO being one of the “best performers” in the market. It had a two-week track record, and had done nothing fundamental to earn its tag as a “best performer.”
Help employers find you! Check out all the jobs and post your resume.
comments powered by